Literature DB >> 27193358

Disability Rating Scales in Parkinson's Disease: Critique and Recommendations.

Lisa M Shulman1, Melissa Armstrong2, Terry Ellis3, Ann Gruber-Baldini4, Fay Horak5, Alice Nieuwboer6, Sotirios Parashos7, Bart Post8, Mark Rogers9, Andrew Siderowf10, Christopher G Goetz11, Anette Schrag12, Glenn T Stebbins11, Pablo Martinez-Martin13.   

Abstract

INTRODUCTION: PD is associated with impairments that progress over time to disability. A large number of disability scales exist with little information on the best choice in PD.
METHODS: Following methodology adopted by the International Parkinson and Movement Disorder Society Task Force, a review of disability scales used in PD was completed. Based on prespecified criteria, the review categorized scales into: "Recommended"; "Recommended with Further Validation in PD Required" when well-validated scales have not been specifically tested for clinimetric properties in PD; "Suggested"; and "Listed."
RESULTS: Twenty-nine disability instruments were identified with nine scales fulfilling criteria for "Recommended" and 7 "Recommended with Further Validation in PD Required." Eight scales are "Suggested" and five scales are "Listed" for use in PD. The nine Recommended scales (Functional Status Questionnaire, Lawton-Brody Activities of Daily Living, Nottingham Activities of Daily Living, Schwab and England Activities of Daily Living, Self-Assessment PD Disability, Short Parkinson's Evaluation Scale/Scales for Outcomes in PD, Unified PD Rating Scale-II: Activities of Daily Living, Movement Disorders Society UPDRS Motor Experiences of Daily Living, PROMIS® and Neuro-QoL Physical Function), and the seven Recommended with Further Validation in PD Required are reviewed.
CONCLUSION: Many disability measures are available and recommended for application in PD. The Task Force does not recommend the development of a new scale. Selection of the most appropriate instrument for a particular objective requires consideration of the characteristics of each scale and the goals of the assessment.
© 2016 International Parkinson and Movement Disorder Society. © 2016 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; disability; rating scales

Mesh:

Year:  2016        PMID: 27193358     DOI: 10.1002/mds.26649

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  19 in total

1.  Progression in Parkinson's Disease: Variation in Motor and Non-motor Symptoms Severity and Predictors of Decline in Cognition, Motor Function, Disability, and Health-Related Quality of Life as Assessed by Two Different Methods.

Authors:  Paulo Bugalho; Filipa Ladeira; Raquel Barbosa; João P Marto; Claudia Borbinha; Laurete da Conceição; Manuel Salavisa; Marlene Saraiva; Bruna Meira; Marco Fernandes
Journal:  Mov Disord Clin Pract       Date:  2021-06-19

2.  Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.

Authors:  Emily J Hill; C Grant Mangleburg; Isabel Alfradique-Dunham; Brittany Ripperger; Amanda Stillwell; Hiba Saade; Sindhu Rao; Oluwafunmiso Fagbongbe; Rainer von Coelln; Arjun Tarakad; Christine Hunter; Robert J Dawe; Joseph Jankovic; Lisa M Shulman; Aron S Buchman; Joshua M Shulman
Journal:  Parkinsonism Relat Disord       Date:  2021-02-10       Impact factor: 4.891

3.  The sobering and puzzling reality of rehabilitation referrals for Parkinson disease.

Authors:  Leland E Dibble; Theresa D Ellis
Journal:  Parkinsonism Relat Disord       Date:  2021-02-01       Impact factor: 4.891

4.  Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's Disease.

Authors:  Connie Marras; Kelly A Mills; Shirley Eberly; David Oakes; Kelvin L Chou; Matthew Halverson; Sotirios A Parashos; Christopher G Tarolli; Jin-Shei Lai; Cindy J Nowinsky; Oksana Suchowersky; Eric S Farbman; Lisa M Shulman; Tanya Simuni
Journal:  Mov Disord       Date:  2021-05-13       Impact factor: 9.698

5.  Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.

Authors:  Keisuke Suzuki; Yasuyuki Okuma; Tomoyuki Uchiyama; Masayuki Miyamoto; Ryuji Sakakibara; Yasushi Shimo; Nobutaka Hattori; Satoshi Kuwabara; Toshimasa Yamamoto; Yoshiaki Kaji; Shigeki Hirano; Taro Kadowaki; Koichi Hirata
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-08-28       Impact factor: 10.154

6.  Psychometric Evaluation of the Parkinson's Disease Activities of Daily Living Scale.

Authors:  Stina B Jonasson; Peter Hagell; Gun-Marie Hariz; Susanne Iwarsson; Maria H Nilsson
Journal:  Parkinsons Dis       Date:  2017-09-25

Review 7.  Inventory of real world data sources in Parkinson's disease.

Authors:  Audrey Tanguy; Linus Jönsson; Lianna Ishihara
Journal:  BMC Neurol       Date:  2017-12-08       Impact factor: 2.474

Review 8.  Rating Scales for Movement Disorders With Sleep Disturbances: A Narrative Review.

Authors:  Carmen Rodríguez-Blázquez; Maria João Forjaz; Monica M Kurtis; Roberta Balestrino; Pablo Martinez-Martin
Journal:  Front Neurol       Date:  2018-06-07       Impact factor: 4.003

9.  Self-Assessment of Disability in Parkinson's Disease: The MDS-UPDRS Part II Versus Clinician-Based Ratings.

Authors:  Carmen Rodríguez-Blázquez; Mario Alvarez; Tomoko Arakaki; Víctor Campos Arillo; Pedro Chaná; William Fernández; Nélida Garretto; Juan Carlos Martínez-Castrillo; Mayela Rodríguez-Violante; Marcos Serrano-Dueñas; Diego Ballesteros; Jose Manuel Rojo-Abuin; Kallol Ray Chaudhuri; Marcelo Merello; Pablo Martínez-Martín
Journal:  Mov Disord Clin Pract       Date:  2017-01-05

10.  A Scale to Assess Activities of Daily Living in Pantothenate Kinase-Associated Neurodegeneration.

Authors:  Randall D Marshall; Abigail Collins; Maria L Escolar; H A Jinnah; Thomas Klopstock; Michael C Kruer; Aleksandar Videnovic; Amy Robichaux-Viehoever; Laura Swett; Dennis A Revicki; Randall H Bender; William R Lenderking
Journal:  Mov Disord Clin Pract       Date:  2019-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.